Associated Papers
A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors.
Siu LL et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2025
40875525 (PubMed )
Supplement: ccr-25-1648_supplementary_table_s5_suppts5.xlsx › Sheet1
ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.
Riabov V et al.
Haematologica, 2024
Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality.
Hansen JW et al.
Blood, 2020
DNMT3A mutations in myeloproliferative neoplasms.
Stegelmann F et al.
Leukemia, 2011
Select a paper to view details